英文名稱 | Tolterodine Tartrate |
---|---|
中文名稱 | 酒石酸托特羅定 |
CAS號(hào) | 124937-52-6 |
分子式 | C26H37NO7 |
分子量 | 475.57 |
外觀 | White to off-white powder |
儲(chǔ)存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
規(guī)格 | 庫(kù)存 | 目錄價(jià) | 會(huì)員專享價(jià) | 數(shù)量 |
---|---|---|---|---|
25 mg | 3-5days | ¥500.00 | 登錄后可見(jiàn) | |
50 mg | 3-5days | ¥750.00 | 登錄后可見(jiàn) | |
100 mg | 3-5days | ¥1200.00 | 登錄后可見(jiàn) |
英文名稱 | Tolterodine Tartrate |
---|---|
中文名稱 | 酒石酸托特羅定 |
CAS號(hào) | 124937-52-6 |
分子式 | C26H37NO7 |
分子量 | 475.57 |
外觀 | White to off-white powder |
儲(chǔ)存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Tolterodine, also known as PNU-200583E, s an antimuscarinic drug that is used for symptomatic treatment of urinary incontinence. Tolterodine acts on M2 and M3 subtypes of muscarinic receptors whereas older antimuscarinic treatments for overactive bladder act more specifically on M3 receptors. Tolterodine, although it acts on all types of receptors, has fewer side effects than oxybutynin (M3 and M1 selective, but more so in the parotid than in the bladder) as tolterodine targets the bladder more than other areas of the body.